ABIOMED/ US0036541003 /
2022-12-21 9:59:52 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
381.19USD | - | 346,755 Turnover: 132.07 mill. |
-Bid Size: - | -Ask Size: - | 17.18 bill.USD | - | 127.01 |
Fundamentals
FY 2022 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 3.00 USD | -40.00% |
EPS Diluted: | 2.98 USD | -39.68% |
Revenues per Share: | 22.64 USD | 21.02% |
Book Value per Share: | 32.99 USD | 12.39% |
Cash Flow per Share: | 6.26 USD | 3.33% |
Dividend per Share: | - USD | - |
Total | in mill. | |
Revenues: | 1,031.75 USD | 21.74% |
Net Income: | 136.51 USD | -39.47% |
Operating Cash Flow: | 285.39 USD | - |
Cash and Cash Equivalents: | 132.82 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 127.01 | 110.41 |
P/S Ratio: | 16.83 | 14.63 |
P/BV ratio: | 11.55 | 10.04 |
P/CF Ratio: | 60.83 | 52.88 |
PEG: | -3.18 | -2.76 |
Earnings Yield: | 0.79% | 0.91% |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 17.18 bill. USD | 15.09 bill. USD |
Free Float Market Cap.: | - USD | 11.11 bill. USD |
Market Cap. / Employee: | 8.67 mill. USD | 7.53 mill. USD |
Shares Outstanding: | 45.09 mill. |
Profitability
Gross Profit Margin: | 100.00% |
EBIT Margin: | 13.64% |
Net Profit Margin: | 13.23% |
Return on Equity: | 9.08% |
Return on Assets: | 8.16% |
Financial Strength
Liquidity I / Cash Ratio: | 95.93% |
Liquidity II / Quick Ratio: | 161.37% |
Liquidity III / Current Ratio: | 705.25% |
Debt / Equity Ratio: | 11.31% |
Dynam. Debt / Equity Ratio: | 59.59% |
Efficiency
Employees: | 2,003 |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | 515,103.84 USD |
Net Income / Employee: | 68,150.27 USD |
Total Assets / Employee: | 835,443.34 USD |
* Fiscal Year End: | 2022-03-31 |
Accounting Standard: | US GAAP |
Currency: | USD |